Peri-Conceptional A1C and Risk of Serious Adverse Pregnancy Outcome in 933 Women With Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To study the association between peri-conceptional A1C and serious adverse pregnancy outcome (congenital malformations and perinatal mortality). RESEARCH DESIGN AND METHODS: Prospective data were collected in 933 singleton pregnancies complicated by type 1 diabetes. RESULTS: The risk of serious adverse outcome at different A1C levels was compared with the background population. The risk was significantly higher when peri-conceptional A1C exceeded 6.9%, and the risk tended to increase gradually with increasing A1C. Women with A1C exceeding 10.4% had a very high risk of 16%. Congenital malformation rate increased significantly at A1C above 10.4%, whereas perinatal mortality was increased even at A1C below 6.9%. CONCLUSIONS: These results support recent guidelines of preconceptional A1C levels <7% in women with type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Observational studies in preexisting diabetes and pregnancy show the lowest rates of adverse fetal outcomes in association with A1C <6-6.5% (<42-48 mmol/mol) early in gestation (4-6,40).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“It has, however, also been reported (20) that there is a stable degree of anomaly risk of 3.9% to 5.0% with a periconceptional HbA1C of up to 10.4%”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [20]
In the citing paper
“with this risk then climbing to 10.9% if the HbA1C is 10.4% or higher.”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evers, I. M., de Valk, H. W., & Visser, G. H. A. (2004) · BMJ · doi:10.1136/bmj.38043.583160.ee · Cited by 775
Miller, E., Hare, J. W., Cloherty, J. P., Dunn, P. J., Gleason, R. E., Soeldner, J. S., & Kitzmiller, J. L. (1981) · New England Journal of Medicine · doi:10.1056/nejm198105283042204 · Cited by 665
Outcomes in Type 1 Diabetic Pregnancies
Jensen, D. M., Damm, P., Moelsted-Pedersen, L., Ovesen, P., Westergaard, J. G., Moeller, M., & Beck-Nielsen, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2819 · Cited by 486 · cited 6×
“The central data registration was performed by Susanne Joergensen, Danish Diabetes Association.”
BackgroundMethodInfluentialSelf-citationManaging preexisting diabetes for pregnancy
Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-9020 · Cited by 476
HbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331 · cited 1×
“We used a reference based on A1C values outside pregnancy, and although A1C has been shown to decline during pregnancy (12), this is not until later stages of gestation.”
MethodSelf-citationSuhonen, L., Hiilesmaa, V., & Teramo, K. (2000) · Diabetologia · doi:10.1007/s001250050010 · Cited by 302
Pregnancy outcomes in the Diabetes Control and Complications Trial
(1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70683-x · Cited by 278
Prepregnancy Care and Pregnancy Outcomes in Women With Type 1 Diabetes
Temple, R. C., Aldridge, V. J., & Murphy, H. R. (2006) · Diabetes Care · doi:10.2337/dc05-2265 · Cited by 184
Hanson, U., Persson, B., & Thunell, S. (1990) · Diabetologia · doi:10.1007/bf00401047 · Cited by 176
Temple, R. C., Aldridge, V., Greenwood, R., Heyburn, P., Sampson, M., & Stanley, K. (2002) · BMJ · doi:10.1136/bmj.325.7375.1275 · Cited by 151
HbA1c in Early Diabetic Pregnancy and Pregnancy Outcomes
Nielsen, G. L., Møller, M., & Sørensen, H. T. (2006) · Diabetes Care · doi:10.2337/dc06-0914 · Cited by 140 · cited 1×
“(5) reported a dose-dependent association between the risk for adverse pregnancy outcome (abortion, stillbirth, neonatal death, or major congenital malformation) and first trimester A1C without any threshold value.”
BackgroundSelf-citationMcElduff, A., Cheung, N. W., McIntyre, D. H., Lagstrom, J., Walters, B. N. J., Oats, J. J. N., Wein, P., Ross, G. P., & Simmons, D. S. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb07087.x · Cited by 138
Cited by
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Japanese clinical practice guideline for diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00439-5 · Cited by 545
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002960 · Cited by 470
Metadata
- Authors
- Jensen, D. M., Korsholm, L., Ovesen, P., Beck-Nielsen, H., Moelsted-Pedersen, L., Westergaard, J. G., Moeller, M., & Damm, P.
- Affiliations
- University of Southern Denmark (DK)
- Aarhus University Hospital (DK)
- Department of Endocrinology, Odense University Hospital, University of Southern Denmark, Odense, Denmark;
- Department of Obstetrics and Gynecology, Copenhagen County Hospital, University of Copenhagen, Copenhagen, Denmark;
- Odense University Hospital (DK)
- Department of Obstetrics and Gynecology, Aalborg University Hospital, Aalborg, Denmark;
- University of Copenhagen (DK)
- Corresponding author
- Jensen, Dorte M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-03-05
- Volume
- 32
- Issue
- 6
- Pages
- 1046-1048
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681038
- OpenAlex
- W2108100082
- Cited by
- 227
- References
- 14
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 13 · 2023: 14 · 2022: 22 · 2021: 16 · 2020: 24 · 2019: 14 · 2018: 18 · 2017: 12 · 2016: 16 · 2015: 11 · 2014: 9 · 2013: 7 · 2012: 11
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Diabetesforeningen
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 1 diabetes, HbA1c, preconception care, pregnancy outcomes, congenital malformations, perinatal mortality, glycemic control
- MeSH terms
- Chromosome Aberrations, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Infant, Newborn, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Prospective Studies, Retrospective Studies, Body Mass Index, White People, Perinatal Mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.